Uni-Bio Science Group Limited
UNBSF
$0.0036
$0.00360.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -50.85% | -50.94% | 71.49% | 71.38% | 31.98% |
| Total Depreciation and Amortization | -25.85% | -25.99% | 41.51% | 41.45% | 92.56% |
| Total Amortization of Deferred Charges | 816.73% | 813.88% | -- | -- | -4.42% |
| Total Other Non-Cash Items | 115.61% | 115.21% | -44.87% | -44.78% | -12.75% |
| Change in Net Operating Assets | -691.93% | -690.87% | -- | -- | 180.42% |
| Cash from Operations | -81.44% | -81.48% | 78.56% | 78.46% | 75.28% |
| Capital Expenditure | 36.07% | 36.19% | -- | -- | -110.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2,962.71% | -2,957.65% | -82.04% | -81.93% | -25.16% |
| Cash from Investing | -135.62% | -135.18% | -82.04% | -81.93% | -136.40% |
| Total Debt Issued | 53.88% | 53.88% | -- | -- | 222.15% |
| Total Debt Repaid | -16.64% | -16.64% | -- | -- | -386.45% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -380.61% | -380.61% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1,759.61% | -1,759.61% | 3,839.19% | 3,839.19% | 82.03% |
| Cash from Financing | -89.64% | -89.66% | 3,851.22% | 3,849.76% | 588.33% |
| Foreign Exchange rate Adjustments | 1,219.06% | 1,216.92% | -38.41% | -38.33% | -5.19% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -367.67% | -367.18% | 1,140.53% | 1,140.13% | 105.35% |